Sanofi Industry Symposium

How to optimize the treatment sequence in Relapsed and Refractory Multiple Myeloma patients – Evidence based Medicine.

October 4th, 2020 – 12:30 to 14:00

Mohamad Mohty and Hermann Einsele
First line treatment options and how they impact the following treatment decisions
Thierry Facon
The role of Pomalidomide in the treatment of Lenalidomide-refractory multiple myeloma.
Maria Vitoria Mateos
AntiCD38 antibody therapy in Lenalidomide-Refractory Multiple Myeloma patients: evidence-based therapy considerations
Philippe Moreau
Health-related quality of life in patients with relapsed/refractory multiple myeloma
Kwee Yong

Q&A and Panel discussion “How to optimize the treatment sequence in Relapsed-and Refractory Multiple Myeloma patients”.
Moderator: Mohamad Mohty
Panel: Hermann Einsele, Thierry Facon, Philippe Moreau, Maria Vitoria Mateos, Kwee Yong